UnitedHealth Group (NYSE: UNH) is scheduled to report third quarter 2019 earnings on Tuesday, October 15, before the market opens. Analysts forecast the company will report earnings of $3.75 per share on revenue of $59.7 billion. This compares to earnings of $3.41 per share on revenue of $56.5 billion reported in the prior-year period.
In the trailing four quarters, the company has consistently beat earnings estimates and this trend can be expected to continue in the to-be-reported quarter. The strength in the Medicare and Optum businesses is likely to continue in the third quarter while membership growth maintains its momentum.
The company is likely to benefit from its investments in growth initiatives and strategic acquisitions. The efficient management of medical costs is also likely to help the quarterly results. Investments in artificial intelligence and other technologies are gaining prominence in the health industry.
In the second quarter of 2019, UnitedHealth Group beat market expectations for earnings while revenues were in line with estimates. Total revenues grew 8% year-over-year to $60.6 billion and adjusted EPS improved by 15% to $3.60. Revenue results were driven by double-digit growth at UnitedHealthcare Medicare & Retirement, OptumRx and OptumHealth. Revenues grew 6% in the UnitedHealthcare segment and 13% in the Optum segment.
For fiscal year 2019, UnitedHealth expects GAAP EPS of $13.95-14.15 and adjusted EPS of $14.70-14.90.
Shares of UnitedHealth have fallen over 10% year-to-date. However, the majority of analysts have rated the stock as Buy and it has an average price target of $290.62.
Most Popular
StubHub Holdings set to enter public markets. Here’s what to expect
After a modest start to the year, the IPO market is witnessing an increase in activity led by technology and healthcare companies. StubHub Holdings, a leading online ticket marketplace for
Can Beyond Meat (BYND) overcome its persistent challenges?
Shares of Beyond Meat, Inc. (NASDAQ: BYND) stayed red on Tuesday. The stock has dropped 19% over the past three months. The plant-based meat company continues to struggle in terms
CarMax (KMX) likely to report strong earnings growth for Q4 2025
After reporting robust earnings growth for the third quarter, CarMax, Inc. (NYSE: KMX) is preparing to publish Q4 results next week. Over the years, the company has fostered customer loyalty
